Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An update on genomic-guided therapies for pediatric solid tumors.

Future oncology (London, England) - 1 Jun 2017

Tsui Pui Chi, Lee Yin-Fai, Liu Zoey Wing Yee, Ip Laura Ren Huey, Piao Wenying, Chiang Alan Kwok Shing, Lui Vivian Wai Yan

Abstract excerpt

Currently, out of the 82 US FDA-approved targeted therapies for adult cancer treatments, only three are approved for use in children irrespective of their genomic status. Apart from leukemia, only a handful of genomic-based trials involving children with solid tumors are ongoing. Emerging genomic data for pediatric solid tumors may facilitate the development of precision medicine in pediatric patients. Here, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Exome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Exome Sequencing

Share to Genomics

Share to Molecular Targeted Therapy

Share to Neoplasms

Share to Precision Medicine

Share to Sequence Analysis, DNA

Source

Identifiers

PMID: 28589766
DOI: 10.2217/fon-2017-0003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An update on genomic-guided therapies for pediatric solid tumors.PMID 28589766Read ↗

Genomics-Driven Precision Medicine in Pediatric Solid TumorsSemantic proximity Read ↗

Future of Clinical Genomics in Pediatric OncologySemantic proximity Read ↗

Molecular Alterations in Pediatric Solid Tumors.Semantic proximity Read ↗

Data-driven approaches to advance research and clinical care for pediatric cancer.Semantic proximity Read ↗

Molecular Markers of Pediatric Solid Tumors—Diagnosis, Optimizing Treatments, and Determining Susceptibility: Current State and Future DirectionsSemantic proximity Read ↗

Comprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical CareSemantic proximity Read ↗

Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunitiesSemantic proximity Read ↗

Molecular Screening for Cancer Treatment Optimization (MOSCATO-01) in Pediatric Patients: A Single-Institutional Prospective Molecular Stratification Trial.Semantic proximity Read ↗

Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours.Semantic proximity Read ↗

Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer.Semantic proximity Read ↗

Genomic alterations in pediatric tumors: clinical relevance and translational insightsSemantic proximity Read ↗

The genomic landscape of pediatric cancers: Implications for diagnosis and treatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.